SCHEMBL14166374

SCHEMBL14166374

O=C(O)NC(c1ccccc1)c1cc(Br)cc(OCCCCCCCCC2OCCO2)c1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.36
BRD4 O60885 1/20 0.36
HRH3 Q9Y5N1 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TAAR1 Q96RJ0 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HTR1A P08908 4/20 0.35
ADRA1D P25100 4/20 0.35
ADRA1A P35348 4/20 0.35
ADRA1B P35368 4/20 0.35
HDAC2 Q92769 1/20 0.34
ACACB O00763 1/20 0.34
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14166245 0.88 HDAC1 (0.40) HDAC1BRD4HRH3MEN1KMT2A
SCHEMBL14166237 0.88 MEN1 (0.44) HRH3MEN1KMT2ATAAR1KDM4E
SCHEMBL17074623 0.88 MEN1 (0.44) HRH3MEN1KMT2ATAAR1KDM4E
SCHEMBL14166156 0.83 BRD4 (0.41) HDAC1BRD4KMT2AKDM4EALDH1A1
SCHEMBL14706817 0.82 CHRM3 (0.58)
SCHEMBL14166159 0.82 HTR1A (0.31) HDAC1BRD4KMT2AKDM4EALDH1A1
SCHEMBL17074679 0.81 KDM4E (0.38) HDAC1BRD4HRH3MEN1KMT2A
SCHEMBL14241188 0.81 CHRM3 (0.40)
SCHEMBL14166623 0.77
SCHEMBL14241392 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718280-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMA SPA (IT) 2015-09-16 EP disclosed
EP-2718280-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Chiesi Farmaceutici S.p.A. (IT) 2014-04-16 EP disclosed
WO-2012168359-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2012-12-13 WO disclosed